Clinical Trials
235 trialsNCT06299540 2026-06-05
QOLIBRI
Janssen Cilag S.A.S.
Recruiting
NCT07602088 2026-06-05
REALITY-RO
Janssen Research & Development, LLC
Recruiting
NCT05557695 2026-06-02
EPIC
AstraZeneca
Recruiting
NCT06092879 2026-05-29
ASSURE-3
Novartis
Active not recruiting
NCT05437250 2026-05-28
NAOS
AstraZeneca
Active not recruiting
NCT07607327 2026-05-26
FORWARD
CareDx
Not yet recruiting
NCT07143669 2026-05-22
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
Recruiting
NCT06548152 2026-05-19
AQUALIS
AstraZeneca
Recruiting
NCT07454850 2026-05-18
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Novartis
Not yet recruiting
NCT07549516 2026-05-15
ASC2ADHERE
Novartis
Recruiting
NCT05041309 2026-05-14
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Gilead Sciences
Enrolling by invitation
NCT05140369 2026-05-14
CLL registry
AstraZeneca
Active not recruiting
NCT06125795 2026-05-01
PROVIDENCE
AbbVie
Active not recruiting
NCT06476665 2026-04-28
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
Pfizer
Active not recruiting
NCT06205498 2026-04-23
ARISE
AstraZeneca
Active not recruiting
NCT05943522 2026-04-20
Asciminib RMP Study
Novartis
Recruiting
NCT07288515 2026-04-17
ALICIA(BY)
AstraZeneca
Recruiting
NCT06297161 2026-04-14
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Pfizer
Recruiting
NCT06170671 2026-03-23
REACH
AstraZeneca
Active not recruiting
NCT04635384 2026-03-18
ACROBAT
CareDx
Active not recruiting
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
NCT05189639 2026-03-12
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Pfizer
Recruiting
NCT05332054 2026-03-12
LTFS
Caribou Biosciences, Inc.
Enrolling by invitation
NCT05999877 2026-03-10
PICAROS
AstraZeneca
Active not recruiting
NCT07458542 2026-03-09
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Bristol-Myers Squibb
Active not recruiting
NCT07154823 2026-03-03
Aquarius
Tempus AI
Recruiting
NCT05974150 2026-02-23
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
Recruiting
NCT06565975 2026-02-12
RELION
Bristol-Myers Squibb
Completed
NCT06181734 2026-02-10
CONFIDHENCE
iOMEDICO AG
Completed
NCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT07374120 2026-02-02
Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
Novartis
Completed
NCT06043011 2026-01-28
RUBIN
iOMEDICO AG
Recruiting
NCT06357754 2026-01-22
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Bristol-Myers Squibb
Recruiting
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT03987958 2026-01-16
REVIVE
AbbVie
Active not recruiting
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT05215639 2025-12-10
VALOR
AbbVie
Completed
NCT03342144 2025-12-08
VeRVe
AbbVie
Recruiting
NCT04746950 2025-12-08
ALICIA
AstraZeneca
Active not recruiting
NCT06906380 2025-12-08
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
ARCE Therapeutics, Inc.
Not yet recruiting
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT04178317 2025-12-04
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
AbbVie
Completed
NCT05645172 2025-12-01
RETAIN
AstraZeneca
Active not recruiting
NCT05424562 2025-11-28
LIVEN
AbbVie
Active not recruiting
NCT04826523 2025-11-26
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
AbbVie
Completed
NCT06362044 2025-11-25
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
AbbVie
Completed
NCT06143839 2025-11-20
VYSION
Jazz Pharmaceuticals
Completed
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT05326308 2025-09-23
ARIADNE
iOMEDICO AG
Recruiting
NCT07188428 2025-09-23
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
Novartis
Completed